| Properties | Information | |
|---|---|---|
| PhytoCAT-ID | PhytoCAT-2069 | |
| Phytochemical name or plant extracts | Eugenia pyriformis (EP-EO) essential oil | |
| PMID | 31549535 | |
| Literature evidence | These results showed, for the first time, the effectiveness of EP-EO as a natural product which has promising biological activities, a fact that enables its ethnopharmacological use. | |
| IUPAC name | NA | |
| Phytochemicals’ class or type of plant extracts | Essential oil | |
| Source of phytochemicals or plant Extracts | Eugenia pyriformis | |
| Geographical availability | Argentina Northeast, Bolivia, Brazil South, Brazil Southeast, Brazil West-Central, Paraguay | |
| Plant parts | Aerial parts | |
| Other cancers | Breast cancer, Cervical cancer, Glioma | |
| Target gene or protein | NA | |
| Gene or Protein evidence | NA | |
| Target pathways | NA | |
| IC50 | 73.09 ± 1.97 μg/ml against MCF-7 | |
| Potency | Concerning the antiproliferative activity of EP-EO, results showed not only low toxicity of the oil on the non-tumoral line (GM07492A), but also demonstrated selectivity against human tumor lines (MCF-7, HeLa and M059J). | |
| Cell line/ mice model | MCF-7, HeLa, M059J | |
| Additional information | NA | |
| PubChem ID | NA | |
| Additional PMIDs | NA | |
| Additional sources of information | https://powo.science.kew.org/taxon/urn:lsid:ipni.org:names:595694-1 | |
| Safety | NA |